Squalamine: GENR began a U.S. Phase I trial of squalamine in an undisclosed number of patients with fibrodysplasia ossificans progressiva, a genetic disorder in

Genaera Corp. (GENR), Plymouth Meeting, Penn.
Product:

Read the full 73 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE